United States Non Narcotic Analgesics Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Non Narcotic Analgesics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Non Narcotic Analgesics Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Non Narcotic Analgesics Overall Market Size
2.1 United States Non Narcotic Analgesics Market Size: 2021 VS 2027
2.2 United States Non Narcotic Analgesics Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Non Narcotic Analgesics Sales: 2016-2027
3 Company Landscape
3.1 Top Non Narcotic Analgesics Players in United States Market
3.2 Top United States Non Narcotic Analgesics Companies Ranked by Revenue
3.3 United States Non Narcotic Analgesics Revenue by Companies
3.4 United States Non Narcotic Analgesics Sales by Companies
3.5 United States Non Narcotic Analgesics Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Non Narcotic Analgesics Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Non Narcotic Analgesics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non Narcotic Analgesics Players in United States Market
3.8.1 List of Tier 1 Non Narcotic Analgesics Companies in United States
3.8.2 List of Tier 2 and Tier 3 Non Narcotic Analgesics Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Non Narcotic Analgesics Market Size Markets, 2021 & 2027
4.1.2 Non Steroid Antiinflammatory Drug
4.1.3 Steroid Antiinflammatory Drug
4.2 By Type - United States Non Narcotic Analgesics Revenue & Forecasts
4.2.1 By Type - United States Non Narcotic Analgesics Revenue, 2016-2021
4.2.2 By Type - United States Non Narcotic Analgesics Revenue, 2022-2027
4.2.3 By Type - United States Non Narcotic Analgesics Revenue Market Share, 2016-2027
4.3 By Type - United States Non Narcotic Analgesics Sales & Forecasts
4.3.1 By Type - United States Non Narcotic Analgesics Sales, 2016-2021
4.3.2 By Type - United States Non Narcotic Analgesics Sales, 2022-2027
4.3.3 By Type - United States Non Narcotic Analgesics Sales Market Share, 2016-2027
4.4 By Type - United States Non Narcotic Analgesics Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Non Narcotic Analgesics Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Medical Center
5.1.4 Others
5.2 By Application - United States Non Narcotic Analgesics Revenue & Forecasts
5.2.1 By Application - United States Non Narcotic Analgesics Revenue, 2016-2021
5.2.2 By Application - United States Non Narcotic Analgesics Revenue, 2022-2027
5.2.3 By Application - United States Non Narcotic Analgesics Revenue Market Share, 2016-2027
5.3 By Application - United States Non Narcotic Analgesics Sales & Forecasts
5.3.1 By Application - United States Non Narcotic Analgesics Sales, 2016-2021
5.3.2 By Application - United States Non Narcotic Analgesics Sales, 2022-2027
5.3.3 By Application - United States Non Narcotic Analgesics Sales Market Share, 2016-2027
5.4 By Application - United States Non Narcotic Analgesics Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Sanofi S.A.
6.1.1 Sanofi S.A. Corporation Information
6.1.2 Sanofi S.A. Overview
6.1.3 Sanofi S.A. Non Narcotic Analgesics Sales and Revenue in United States Market (2016-2021)
6.1.4 Sanofi S.A. Non Narcotic Analgesics Product Description
6.1.5 Sanofi S.A. Recent Developments
6.2 Novartis AG
6.2.1 Novartis AG Corporation Information
6.2.2 Novartis AG Overview
6.2.3 Novartis AG Non Narcotic Analgesics Sales and Revenue in United States Market (2016-2021)
6.2.4 Novartis AG Non Narcotic Analgesics Product Description
6.2.5 Novartis AG Recent Developments
6.3 GlaxoSmithKline PLC
6.3.1 GlaxoSmithKline PLC Corporation Information
6.3.2 GlaxoSmithKline PLC Overview
6.3.3 GlaxoSmithKline PLC Non Narcotic Analgesics Sales and Revenue in United States Market (2016-2021)
6.3.4 GlaxoSmithKline PLC Non Narcotic Analgesics Product Description
6.3.5 GlaxoSmithKline PLC Recent Developments
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Overview
6.4.3 Pfizer Non Narcotic Analgesics Sales and Revenue in United States Market (2016-2021)
6.4.4 Pfizer Non Narcotic Analgesics Product Description
6.4.5 Pfizer Recent Developments
6.5 Reckitt Benckiser
6.5.1 Reckitt Benckiser Corporation Information
6.5.2 Reckitt Benckiser Overview
6.5.3 Reckitt Benckiser Non Narcotic Analgesics Sales and Revenue in United States Market (2016-2021)
6.5.4 Reckitt Benckiser Non Narcotic Analgesics Product Description
6.5.5 Reckitt Benckiser Recent Developments
6.6 Endo Pharmaceuticals
6.6.1 Endo Pharmaceuticals Corporation Information
6.6.2 Endo Pharmaceuticals Overview
6.6.3 Endo Pharmaceuticals Non Narcotic Analgesics Sales and Revenue in United States Market (2016-2021)
6.6.4 Endo Pharmaceuticals Non Narcotic Analgesics Product Description
6.6.5 Endo Pharmaceuticals Recent Developments
7 United States Non Narcotic Analgesics Production Capacity, Analysis
7.1 United States Non Narcotic Analgesics Production Capacity, 2016-2027
7.2 Non Narcotic Analgesics Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Non Narcotic Analgesics Supply Chain Analysis
9.1 Non Narcotic Analgesics Industry Value Chain
9.2 Non Narcotic Analgesics Upstream Market
9.3 Non Narcotic Analgesics Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Non Narcotic Analgesics Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Non Narcotic Analgesics in United States Market
Table 2. Top Non Narcotic Analgesics Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Non Narcotic Analgesics Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Non Narcotic Analgesics Revenue Share by Companies, 2016-2021
Table 5. United States Non Narcotic Analgesics Sales by Companies, (K Pcs), 2016-2021
Table 6. United States Non Narcotic Analgesics Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Non Narcotic Analgesics Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Non Narcotic Analgesics Product Type
Table 9. List of Tier 1 Non Narcotic Analgesics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Non Narcotic Analgesics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Non Steroid Antiinflammatory Drug
Table 12. Major Manufacturers of Steroid Antiinflammatory Drug
Table 13. By Type - United States Non Narcotic Analgesics Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Non Narcotic Analgesics Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Non Narcotic Analgesics Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Non Narcotic Analgesics Sales (K Pcs), 2016-2021
Table 17. By Type - United States Non Narcotic Analgesics Sales (K Pcs), 2022-2027
Table 18. By Application - United States Non Narcotic Analgesics Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Non Narcotic Analgesics Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Non Narcotic Analgesics Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Non Narcotic Analgesics Sales (K Pcs), 2016-2021
Table 22. By Application - United States Non Narcotic Analgesics Sales (K Pcs), 2022-2027
Table 23. Sanofi S.A. Corporation Information
Table 24. Sanofi S.A. Description and Major Businesses
Table 25. Sanofi S.A. Non Narcotic Analgesics Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Sanofi S.A. Non Narcotic Analgesics Product
Table 27. Sanofi S.A. Recent Developments
Table 28. Novartis AG Corporation Information
Table 29. Novartis AG Description and Major Businesses
Table 30. Novartis AG Non Narcotic Analgesics Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. Novartis AG Non Narcotic Analgesics Product
Table 32. Novartis AG Recent Developments
Table 33. GlaxoSmithKline PLC Corporation Information
Table 34. GlaxoSmithKline PLC Description and Major Businesses
Table 35. GlaxoSmithKline PLC Non Narcotic Analgesics Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. GlaxoSmithKline PLC Non Narcotic Analgesics Product
Table 37. GlaxoSmithKline PLC Recent Developments
Table 38. Pfizer Corporation Information
Table 39. Pfizer Description and Major Businesses
Table 40. Pfizer Non Narcotic Analgesics Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Pfizer Non Narcotic Analgesics Product
Table 42. Pfizer Recent Developments
Table 43. Reckitt Benckiser Corporation Information
Table 44. Reckitt Benckiser Description and Major Businesses
Table 45. Reckitt Benckiser Non Narcotic Analgesics Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Reckitt Benckiser Non Narcotic Analgesics Product
Table 47. Reckitt Benckiser Recent Developments
Table 48. Endo Pharmaceuticals Corporation Information
Table 49. Endo Pharmaceuticals Description and Major Businesses
Table 50. Endo Pharmaceuticals Non Narcotic Analgesics Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Endo Pharmaceuticals Non Narcotic Analgesics Product
Table 52. Endo Pharmaceuticals Recent Developments
Table 53. Non Narcotic Analgesics Production Capacity (K Pcs) of Key Manufacturers in United States Market, 2019-2021 (K Pcs)
Table 54. United States Non Narcotic Analgesics Capacity Market Share of Key Manufacturers, 2019-2021
Table 55. Non Narcotic Analgesics Market Opportunities & Trends in United States Market
Table 56. Non Narcotic Analgesics Market Drivers in United States Market
Table 57. Non Narcotic Analgesics Market Restraints in United States Market
Table 58. Non Narcotic Analgesics Raw Materials
Table 59. Non Narcotic Analgesics Raw Materials Suppliers in United States Market
Table 60. Typical Non Narcotic Analgesics Downstream
Table 61. Non Narcotic Analgesics Downstream Clients in United States Market
Table 62. Non Narcotic Analgesics Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Non Narcotic Analgesics Product Picture
Figure 2. Non Narcotic Analgesics Segment by Type
Figure 3. Non Narcotic Analgesics Segment by Application
Figure 4. United States Non Narcotic Analgesics Market Overview: 2020
Figure 5. United States Non Narcotic Analgesics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Non Narcotic Analgesics Revenue, 2016-2027 (US$, Mn)
Figure 7. Non Narcotic Analgesics Sales in United States Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Non Narcotic Analgesics Revenue in 2020
Figure 9. Non Steroid Antiinflammatory Drug Product Picture
Figure 10. Steroid Antiinflammatory Drug Product Picture
Figure 11. By Type - United States Non Narcotic Analgesics Sales Market Share, 2016-2027
Figure 12. By Type - United States Non Narcotic Analgesics Revenue Market Share, 2016-2027
Figure 13. By Type - United States Non Narcotic Analgesics Price (USD/Pcs), 2016-2027
Figure 14. Hospital
Figure 15. Medical Center
Figure 16. Others
Figure 17. By Application - United States Non Narcotic Analgesics Sales Market Share, 2016-2027
Figure 18. By Application - United States Non Narcotic Analgesics Revenue Market Share, 2016-2027
Figure 19. By Application - United States Non Narcotic Analgesics Price (USD/Pcs), 2016-2027
Figure 20. Sanofi S.A. Non Narcotic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Novartis AG Non Narcotic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. GlaxoSmithKline PLC Non Narcotic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Pfizer Non Narcotic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Reckitt Benckiser Non Narcotic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Endo Pharmaceuticals Non Narcotic Analgesics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. United States Non Narcotic Analgesics Production Capacity (K Pcs), 2016-2027
Figure 27. Non Narcotic Analgesics Industry Value Chain
Figure 28. Marketing Channels